Eloxatin?/Taxotere? Active for Advanced Non?Small Cell Lung Cancer
According to an article recently published in the journal Lung Cancer, the chemotherapy combination consisting of Eloxatin? (oxaliplatin) and Taxotere? (docetaxel) is well-tolerated and provides anticancer activity for patients with advanced non?small cell lung cancer.
This entry was posted on Wednesday, August 23rd, 2006 at 9:23 am and is filed under Research, Non-Small-Cell, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.